Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TOMM22P2 (TOMM22 pseudogene 2) is a pseudogene located on chromosome Y (chrY:2827982-2828218, human genome build hg38), annotated in GenBank and Ensembl as a non-coding, non-functional sequence with sequence similarity to the protein-coding TOMM22 gene, but does not encode a functional mitochondrial protein[5][7]. Pseudogenes do not produce functional proteins and typically lack regulatory or disease relevance; TOMM22P2 is not considered a receptor, enzyme, transporter, nor a therapeutic target. It is distinct from the functional TOMM22 gene (translocase of outer mitochondrial membrane 22 homolog), which is central to mitochondrial protein import, but TOMM22P2 itself is simply a genomic remnant without biological activity or clinical significance[5][7]. TOMM22P2 should not be confused with the functional mitochondrial import receptor subunit TOM22, officially known as TOMM22, which *is* a validated therapeutic target and biomarker in multiple diseases including cancer[1][2][3][11]. TOMM22P2 is annotated in major genomic databases (NCBI Gene: 100499417; Ensembl: ENSG00000232195) as a pseudogene, though these entries contain no evidence for protein expression or function[5][7]. If you require information on TOMM22 (the functional protein-coding gene and receptor), please clarify, as its molecular and therapeutic relevance is entirely distinct from TOMM22P2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TOMM22 pseudogene 2 (TOMM22P2).